United States - English - NLM (National Library of Medicine)

citra labs, llc - sodium pyruvate (unii: pod38aif08) (pyruvic acid - unii:8558g7rutr), inosine (unii: 5a614l51ct) (inosine - unii:5a614l51ct), adenine (unii: jac85a2161) (adenine - unii:jac85a2161), sodium phosphate, dibasic (unii: gr686lba74) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37), sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37) - sodium pyruvate 0.55 g in 50 ml - rejuvesol ® solution is intended only for the extracorporeal rejuvenation of a rbc. it should never be directly administered to humans. rejuvesol ® solution must not be added to whole blood because the additional plasma may reduce the effectiveness of the rejuvenation process. immediately after rejuvenation, rbc must either be washed via an approved protocol prior to transfusion or glycerolized and frozen. rbc which have been rejuvenated, glycerolized, and frozen must be deglycerolized via an approved protocol prior to transfusion. rbc rejuvenated before 6 days of storage may achieve 2,3-dpg levels in excess of 2 times normal and atp levels in excess of 1.5 times normal. 5,6 in patients with reduced arterial blood p0 2 of less than 40 torr, the use of rbc rejuvenated before 6 days of storage are contraindicated because their high 2,3-dpg levels and low oxygen affinity may impair proper oxygenation of the red blood cells in the lung. 7 rej

Australia - English - Department of Health (Therapeutic Goods Administration)

haemonetics australia pty ltd - 46668 - blood storage solution, multi-purpose - a solution used for the de-glycerolisation of cryo-preserved red blood cells during apheresis treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

haemonetics australia pty ltd - 45520 - blood cell processing unit set - to be used with the blood cell processing unit for the glycerolisation of red blood cells.

Singapore - English - HSA (Health Sciences Authority)

transmedic pte ltd - hematology - the acp 215 system can perform the following types of procedures: •prepare collected red blood cell products with glycerol for freezing. •deglycerolize thawed red blood cell products, removing extra cellular components, and re-suspend the red blood cells in an additive solution. •wash red blood cell units stored in commonly used ac and additive solutions to remove plasma and extra cellular components. the ability to process-control the addition and removal of cryroprotectant solution as well as wash banked blood in a closed system significantly improves the safety and availability of blood products.

Australia - English - Department of Health (Therapeutic Goods Administration)

haemonetics australia pty ltd - 46814 - blood storage solution, nutritional - the 300 ml as-3 is used in conjunction with automated red blood cell washing devices. as-3 serves as the nutrient solution for storage of the red blood cell product after deglycerolization. the red blood cells are washed using the model 215 system. as-3 is used for priming the disposable and for the last wash of the red blood cells. the washed cells are then re-suspended in 100 ml of the as-3 before transfer into a product collection bag or storage bag. as-3 provides nutrients to keep the washed red blood cells viable for up to 14 days after washing when refrigerated.

United States - English - NLM (National Library of Medicine)

haemonetics corporation - citric acid monohydrate (unii: 2968phw8qp) (anhydrous citric acid - unii:xf417d3psl), trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl), sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (phosphate ion - unii:nk08v8k8hr), anhydrous dextrose (unii: 5sl0g7r0ok) (anhydrous dextrose - unii:5sl0g7r0ok) - anhydrous citric acid 32.7 mg in 1 ml - for use with haemonetics apheresis devices rx only the haemonetics 250ml anticoagulant citrate phosphate double dextrose (cp2d) and 250ml additive solution formula 3 (as-3) nutrient solution are intended to be used only with automated apheresis devices for collecting human blood and blood components. the anticoagulant solution is metered by the apheresis machine into the collected whole blood. it is not to be infused directly into the donor. after the anticoagulant is used, the bag in which it was contained is discarded. when collecting plasma in the rbcp protocol, the plasma is collected into an empty plasma collection bag. one hundred milliliters (100ml) of as-3 is transferred into one rbc collection bag when using the rbcp protocol or 2 separate bags when using the

United States - English - NLM (National Library of Medicine)

haemonetics corporation - citric acid monohydrate (unii: 2968phw8qp) (anhydrous citric acid - unii:xf417d3psl), sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (phosphate ion - unii:nk08v8k8hr), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), adenine (unii: jac85a2161) (adenine - unii:jac85a2161), anhydrous dextrose (unii: 5sl0g7r0ok) (anhydrous dextrose - unii:5sl0g7r0ok), trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl) - anhydrous citric acid 4.2 mg in 1 ml - the haemonetics 250ml anticoagulant citrate phosphate double dextrose (cp2d) and 250ml additive solution formula 3 (as-3) nutrient solution are intended to be used only with automated apheresis devices for collecting human blood and blood components. the anticoagulant solution is metered by the apheresis machine into the collected whole blood. it is not to be infused directly into the donor. after the anticoagulant is used, the bag in which it was contained is discarded. when collecting plasma in the rbcp protocol, the plasma is collected into an empty plasma collection bag. one hundred milliliters (100ml) of as-3 is transferred into one rbc collection bag when using the rbcp protocol or 2 separate bags when using the 2rbc protocol. as-3 solution provides nutrients to keep the red blood cells viable for 42 days when refrigerated. cp2d is also indicated for the collection of ffp and pf24 plasma, collected and stored plasma collected using the 822, 822-2p and 822f-2p disposable sets may be frozen within 8 hours

United States - English - NLM (National Library of Medicine)

fenwal, inc. - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl), sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (phosphate ion - unii:nk08v8k8hr), adenine (unii: jac85a2161) (adenine - unii:jac85a2161) -

Australia - English - Department of Health (Therapeutic Goods Administration)

haemonetics australia pty ltd -

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

teva czech industries s.r.o. - butamirate (butamirate citrate), guaifenesin - tablets - 4mg+100mg